Interview with Ryan Zimmerman, Managing Director and Medical Technology Analyst, BTIG and former Director of Surgery at ...
Tell us briefly about Picard Medical and the history of SynCardia Total Artificial Heart. Mr. Schnegelsberg: Let me start with SynCardia and then go to Picard. SynCardia is a company with a long ...
For readers who are not familiar with SINTX, give us a brief overview of the company and how it evolved into what it is today. Mr. Olson: SINTX was founded on the use of silicon nitride ceramic ...
In the context of an introduction to your coverage, could you define the life sciences space, and discuss how it differs from the biotech or medtech space? Ms. Utterback: The life science companies ...
For readers who may just be hearing about HeartBeam, explain to us what clinical problem you are trying to solve and why hasn’t that been able to be solved with existing cardiac monitoring tools? Mr.
In the context of an introduction to your coverage, how do you evaluate names in the medtech space? Mr. Zimmerman: The lens we look through is consistency of execution, whether internal expectations ...
It’s been a few years since we featured the company. So could you give us a brief history and some milestones for Aclarion? Mr. Ness: Certainly. We successfully completed an IPO in April of 2022. And ...
We had the chance to interview you a couple years ago, and when we spoke in October 2023, your company was mainly focused on advancing the drug-eluting version of its CanGaroo bioenvelope. What is the ...
The Wall Street Transcript is a completely unique resource for investors and business researchers.
David Swartz is a senior equity analyst, consumer research, for Morningstar, Inc. He covers department stores, specialty retailers, and manufacturers and retailers of apparel, footwear, and ...
Marvin Fong, CFA, is a Director at BTIG with coverage of Consumer and Technology Services, including e-commerce platforms, information service providers, and automotive services. Previously, he ...
Matthew DeCicco, CFA, is Director of Equities and a Portfolio Manager for Lord Abbett & Co. He is responsible for directing Lord Abbett’s equity investment activities, including portfolio management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results